| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3385533 | Revista Colombiana de Reumatología | 2011 | 10 Pages |
Abstract
The purpose of this paper is to analyze the role of the transforming growth factor beta in the pathophysiology of scleroderma emphasizing the signaling pathway mediated by Smad; it is also to review some studies involving these proteins as therapeutic targets of molecules and drugs that could become potential treatments for scleroderma.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Adriana MD, Gloria MD, DSc,